Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature

Indian J Dermatol Venereol Leprol. 2018 Sep-Oct;84(5):539-546. doi: 10.4103/ijdvl.IJDVL_77_17.

Abstract

Paternally transmitted damage to offspring is recognized as a complex issue. Each parent contributes 23 chromosomes to a child; hence, it is necessary to know the effects of both maternal and paternal pre-and peri-conceptional exposure to drugs on pregnancy outcome. While there are many studies on the effects of maternal drug exposure on pregnancy outcome, literature on paternal exposure is scarce. Of late however, paternal exposure has been receiving increasing attention. We present a brief review on the safety of commonly used drugs in dermatology, focused on retinoids, immune suppressants, anti androgens and thalidomide.

Keywords: Antiandrogen; immunosuppressive; reproductively active male; retinoid; safety of drugs; thalidomide.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Androgen Antagonists / adverse effects
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / adverse effects
  • Fathers
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Male
  • Pregnancy
  • Pregnancy Outcome* / epidemiology
  • Reproduction / drug effects*
  • Reproduction / physiology
  • Retinoids / administration & dosage*
  • Retinoids / adverse effects
  • Thalidomide / administration & dosage*
  • Thalidomide / adverse effects

Substances

  • Androgen Antagonists
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Retinoids
  • Thalidomide